Microbial-Based Cancer Imaging And Therapy - Bugs As Drugs (R21 Clinical Trial Not Allowed)

KazakhTenders notice for Microbial-Based Cancer Imaging And Therapy - Bugs As Drugs (R21 Clinical Trial Not Allowed). The reference ID of the tender is 110055111 and it is closing on 07 May 2025.

100% Secure Payments

Tender Details

  • Country: USA
  • Summary: Microbial-Based Cancer Imaging And Therapy - Bugs As Drugs (R21 Clinical Trial Not Allowed)
  • KZT Ref No: 110055111
  • Deadline: 07 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PAR-25-108
  • Purchaser's Detail :
  • Purchaser : NATIONAL INSTITUTES OF HEALTH
    NIH Grants Informationgrantsinfo@nih.gov
    URL :https://www.grants.gov/search-grants

  • Description :
  • Through This Notice Of Funding Opportunity (Nofo), The National Cancer Institute (Nci) Solicits Grant Applications Proposing To Utilize Bacteria, Archaebacteria, Bacteriophages, Or Other Non-Oncolytic Viruses And Their Natural Products To Study The Underlying Mechanisms Of The Complex Interactions Between Microorganisms, Tumors, And The Immune System, And To Explore Their Clinical Potential For Cancer Imaging, Therapeutics Or Diagnostics. Projects Can Focus On Using Microorganisms As Anti-Tumor Agents, As Activators Of Anti-Tumor Immunity, Or As Delivery Vehicles For Treatment, Diagnosis, Or Imaging, Complementing Or Synergizing With Existing Tools And Approaches. This Nofo Will Support Basic Mechanistic And Preclinical Studies In Cell Culture And Animal Models. Applicants Are Encouraged To Address Both The Microbial And Tumor Aspects Of Microbial Tumor Interactions Relevant To Microbial-Based Cancer Therapy (Including Therapies For Oral Cancer), Tumor Imaging, Tumor Detection, Or Diagnosis. The R21 Foa Is Intended To Encourage Exploratory Projects That Are At An Early Conceptual Stage Feasibility Study (Inception Through Preliminary Development) To Demonstrate The Core Functional Capabilities Of The Proposed Approach. The Proposed Projects May Involve Considerable Risk And Should Be Aimed At Producing Breakthroughs In Microbial-Based Cancer Therapy, Imaging, Or Diagnosis. This Funding Opportunity Is Part Of Broader Nci-Sponsored Research On Microbial-Based Cancer Therapy.
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KazakhTenders Features

KazakhTenders Features

Fresh and verified Tenders from Kazakh. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kazakh in your email inbox.

  Chat with us